The PCR reactions occur inside the individual droplets, which the machine then sorts with fluorescent markers to
detect target sequences.
Not exact matches
Advances in genomic
sequencing technologies have improved the ability to
detect molecular aberrations with greater sensitivity and to identify genomic alterations that can be matched to
targeted therapies.
Next, they expanded their search, testing samples from an additional 642 patients with CNS infections using a sensitive polymerase chain reaction (PCR) test developed to specifically
target the
detected sequence.